Zenas BioPharma, Inc. (ZBIO) Earnings
Zenas BioPharma, Inc. is expected to report next earnings on November 12, 2026 (in NaN days), with a consensus EPS estimate of $-1.22. ZBIO has beaten EPS estimates in 1 of its last 6 reported quarters (average surprise -114.5% over the last four).
Next earnings
Nov 12, 2026in NaN days
EPS est $-1.22 · Revenue est $1M
Track record
Beat EPS in 1 of 6 quarters
Avg surprise -114.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 12, 2026 | $-1.12 | $-1.77 | -58.0% | $1M | -93.3% |
| May 13, 2026 | $-1.37 | $-1.46 | -6.6% | — | — |
| Mar 16, 2026 | $-1.00 | $-4.54 | -353.4% | — | — |
| Nov 12, 2025 | $-0.87 | $-1.22 | -40.2% | — | — |
| May 15, 2025 | $-1.11 | $-0.80 | +27.9% | $10M | +700.0% |
| Mar 25, 2025 | $-0.92 | $-3.99 | -333.7% | $5M | — |
| Jun 30, 2024 | — | $-0.99 | — | — | — |
| Mar 31, 2024 | — | $-0.73 | — | — | — |
| Dec 31, 2023 | — | $-0.64 | — | — | — |
| Sep 30, 2023 | — | $0.85 | — | $50M | — |
| Jun 30, 2023 | — | $-0.76 | — | — | — |
| Mar 31, 2023 | — | $-0.50 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.